Rhea Venture Partners
rheavc.com Direct investor
Rhea Venture Partners is a European specialist life sciences venture capital fund. It invests in companies advancing drug development, including breakthrough therapies and the technologies, tools and services that enable new medicines.
Rhea Venture Partners is a venture capital firm. It invests directly in companies, in life sciences, drug development, therapies and technologies.
“Rhea BioVentures is a European specialist life sciences venture capital fund investing in cutting-edge innovation that can change the lives of patients.”
— Rhea Venture Partners, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Invests in
- Europe
- Sectors
- life sciences, drug development, therapies, technologies, tools, services
Team, as Rhea Venture Partners publishes it
- Alexandra Tolia, PhD Managing Partner
- Kenneth Wils Partner
- Stefanos Aivazidis, PhD Associate
- Alexandra Stavropoulou, PhD Analyst & Operations Manager
Names and roles exactly as listed on rheavc.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Rhea Venture Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://rheavc.com/name, is_investor, layer, type, invests_in_geographies, sectors, thesis_quote, description, status
- https://rheavc.com/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 10251 · added 2026-09-29 · link last verified 2026-09-29 · confidence high
Similar investors
- 5Y CapitalVenture capital · Pre-seed – Series B
- Aglaia Management B.V.Venture capital · Bilthoven, Netherlands
- EFI Lake Geneva VenturesVenture capital · Seed – Series A · Geneva, Switzerland
- F-Prime CapitalVenture capital · Seed – Growth · Cambridge, United States
- Foresite CapitalVenture capital · Seed – Growth · United States
- FSG Management ABVenture capital · Lund, Sweden